Select Page

BEST HCP Website for Bronchitol


Bronchitol is an inhaled treatment that helps break up the mucus characteristic in the lungs of patients with Cystic Fibrosis. It’s administered via a small, portable 2-inch-tall inhaler, and can be administered in about 5 minutes from anywhere—which represents an upgrade from current treatments which require a bulky nebulizer and 3 times as long to administer.

The target is the active patient over 18—young college students, finally out on their own, and other adults with busy, on-the-go lives. The brand website, uses dynamic animation to simply communicate the core benefit of Bronchitol with the same campaign for both physicians and patients: that the discrete, portable inhaler that takes just minutes to use can easily fit into patients’ lives.

Check it out at




Because Bronchitol has been shown to cause an intolerable side effect in a small number of patients, clinicians must perform the Bronchitol Tolerance Test (BTT) to evaluate a patient’s ability to tolerate a complete dose. The video below briefly demonstrates how this interactive tool can be utilized in a clinical setting to determine if Bronchitol is appropriate for their patient.